High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

209

HTML

1659

Figures (1-3)

119

Tables (1-2)

113

Sum=2100

Sep 14, 2005 (publication date) through Apr 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 14, 2005; 11(34): 5342-5346
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5342

Figure 1 Trial profile of group A (non-responder) and group B (relapser).

Figure 2 Response rates in relation to former response after IFN-α monotherapy. ¹P = 0.05; ²P = 0.049; χ² test.

Figure 3 Response rates in relation to genotype (genotype 1 vs 2/3). ¹P = 0.005; ²P = 0.001; χ² test.

Citation: Hass HG, Kreysel C, Fischinger J, Menzel J, Kaiser S. High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy. World J Gastroenterol 2005; 11(34): 5342-5346
URL: https://www.wjgnet.com/1007-9327/full/v11/i34/5342.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i34.5342